EUVIMEDEUVIMED entdecken
Crossref

Clinical Features and Therapeutic Alternatives in Eyes with Secondary Vasoproliferative Tumors: A Single-Center Turkish Perspective

Gorkem Polat, Omer Karti, Ziya Ayhan, Murat Tunc, Remzi Avci, Ali Osman Saatci

Czech and Slovak Ophthalmology · 23.03.2026

DOI: 10.31348/2026/18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Czech and Slovak Ophthalmology, online erschienen am 23.03.2026. Verfasst von Gorkem Polat und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Retinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate retrospectively the clinical characteristics and therapeutic outcomes in eyes with secondary vasoproliferative retinal tumors (VPRT) at a tertiary center in Turkey. Material and Methods: Patients diagnosed with secondary VPRT between 2005 and 2025 with a follow-up of 6 months or more were included. 24 eyes of 21 patients were evaluated. Their charts and multimodal imaging features were analyzed, and treatments noted.

Results

Mean age was 26.1 years (6–57). Mean follow-up was 61.1 months (6–151). Baseline BCVA was 0.77 LogMAR (0.00–2.30). VPRT was linked to non-infectious uveitis in 12 patients, retinitis pigmentosa in 5 patients, X-linked Juvenile Retinoschisis, Coats’ disease, retinal dystrophy and retinopathy of prematurity in 1 patient each. The inferotemporal quadrant was the most common site (66.7%). Treatments included dexamethasone implant, transscleral cryotherapy, systemic immunosuppressive therapy, laser photocoagulation, CyberKnife, intravitreal anti-VEGF, vitreoretinal surgery, photodynamic therapy, intravitreal triamcinolone acetonide and enucleation. At baseline, 15 eyes had macular intraretinal fluid. At the final visit, dry macula was achieved in 9 of 15 eyes. Mean final BCVA was 1.01 LogMAR (0.00–3.00). Two eyes deteriorated to no light perception. One was enucleated.

Conclusion

This largest cohort of patients from Turkey with secondary VPRT reflects the diverse underlying etiologic associations and heterogeneous clinical manifestations at a tertiary center. Various therapeutic techniques were required to cope with this difficult-to-treat, challenging disease entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal NeoplasmsHumansTurkeyFemaleMaleAdultRetrospective StudiesChildAdolescentMiddle AgedYoung AdultCryotherapyUveitis

Stichwörter der Autor:innen

cryotherapyDexamethasone implantRetinaVitrectomycyberknifeintravitreal injectionlaser photocoagulationvasoproliferative retinal tumor

Zitieren

APA

Polat, G., Karti, O., Ayhan, Z., Tunc, M., Avci, R., & Saatci, A. O. (2026). Clinical Features and Therapeutic Alternatives in Eyes with Secondary Vasoproliferative Tumors: A Single-Center Turkish Perspective. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2026/18

Vancouver

Polat G, Karti O, Ayhan Z, Tunc M, Avci R, Saatci AO. Clinical Features and Therapeutic Alternatives in Eyes with Secondary Vasoproliferative Tumors: A Single-Center Turkish Perspective. Czech and Slovak Ophthalmology. 2026. doi:10.31348/2026/18

BibTeX
@article{Polat2026,
  author = {Polat, Gorkem and Karti, Omer and Ayhan, Ziya and Tunc, Murat and Avci, Remzi and Saatci, Ali Osman},
  title = {Clinical Features and Therapeutic Alternatives in Eyes with Secondary Vasoproliferative Tumors: A Single-Center Turkish Perspective},
  journal = {Czech and Slovak Ophthalmology},
  year = {2026},
  doi = {10.31348/2026/18}
}
Kostenlos starten →